摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2RS,3S)-3-tert-butyloxycarbonylamino-4-cyclohexyl-2-hydroxybutyric acid | 276888-52-9

中文名称
——
中文别名
——
英文名称
(2RS,3S)-3-tert-butyloxycarbonylamino-4-cyclohexyl-2-hydroxybutyric acid
英文别名
(2RS,3S)-3-tert-butoxycarbonylamino-4-cyclohexyl-2-hydroxybutyric acid;(2RS, 3S)-3-tert-butoxycarbonylamino-4-cyclohexyl-2-hydroxybutyric acid;(3S)-4-cyclohexyl-2-hydroxy-3-[(2-methylpropan-2-yl)oxycarbonylamino]butanoic acid
(2RS,3S)-3-tert-butyloxycarbonylamino-4-cyclohexyl-2-hydroxybutyric acid化学式
CAS
276888-52-9
化学式
C15H27NO5
mdl
——
分子量
301.383
InChiKey
OGIFVSFQVHLIDP-PXYINDEMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3
  • 重原子数:
    21
  • 可旋转键数:
    7
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.87
  • 拓扑面积:
    95.9
  • 氢给体数:
    3
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (2RS,3S)-3-tert-butyloxycarbonylamino-4-cyclohexyl-2-hydroxybutyric acid盐酸1-羟基苯并三唑1-(3-二甲基氨基丙基)-3-乙基碳二亚胺N,N-二异丙基乙胺 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 作用下, 以 1,4-二氧六环N,N-二甲基甲酰胺 为溶剂, 生成 (2R)-N-(2-(((2S)-1-cyclohexyl-3-hydroxy-4-oxo-4-(phenethylamino)butan-2-yl)amino)-2-oxoethyl)-N-methyl-5-((E)-2-nitroguanidino)-2-((phenylmethyl)sulfonamido)pentanamide
    参考文献:
    名称:
    Novel, potent and selective chimeric FXa inhibitors featuring hydrophobic p1-ketoamide moieties
    摘要:
    Judicious combination of P-region sequences of highly potent anticoagulant proteins including NAPS, NAP6, Ecotin, and Antistasin with SAR from small molecule FXa inhibitors led to a series of chimeric inhibitors of formula 1a-j. We report herein the design, synthesis, and biological activity of this novel family of FXa inhibitors that express both high in vitro potency and superb selectivity against related serine proteases. (C) 2000 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(00)00458-3
  • 作为产物:
    参考文献:
    名称:
    通过Passerini反应有效构建α-羟基-β-氨基酰胺的新合成技术。
    摘要:
    [反应:见正文]使用吡啶型碱的N-保护的氨基醛,异腈和TFA的Passerini反应在温和的条件下进行,并以中等至高收率直接提供α-羟基-β-氨基酰胺衍生物。这些加合物容易水解成α-羟基-β-氨基羧酸。说明了这些关键中间体在简明P(1)-α-酮酰胺蛋白酶抑制剂合成中的应用。
    DOI:
    10.1021/ol0061485
点击查看最新优质反应信息

文献信息

  • Morpholine containing amino acid derivatives
    申请人:Kissei Pharmaceutical Co., Ltd.
    公开号:US04711958A1
    公开(公告)日:1987-12-08
    Amino acid derivatives represented by formula ##STR1## wherein His represents an L-histidyl group, X represents a straight or branched alkoxy group having 1 to 7 carbon atoms, a straight or branched alkylamino group having 1 to 7 carbon atoms, a cycloalkyloxy group having 3 to 7 carbon atoms, a morpholino group, said alkoxy group having one or more halogen atoms as substituents; or a pharmaceutically acceptable salt, are useful in the treatment of hypertension.
    公式##STR1##所代表的氨基酸衍生物,其中His代表L-组氨酸基团,X代表具有1至7个碳原子的直链或支链烷氧基团,具有1至7个碳原子的直链或支链烷基氨基基团,具有3至7个碳原子的环烷氧基团,吗啡啉基团,所述烷氧基团具有一个或多个卤素原子作为取代基;或其药学上可接受的盐,在治疗高血压方面是有用的。
  • Novel amino acid derivatives
    申请人:Kissei Pharmaceutical Co., Ltd.
    公开号:US04870183A1
    公开(公告)日:1989-09-26
    Novel amino acid derivatives useful as a therapeutic agent are disclosed. These amino acid derivatives and the pharmaceutically acceptable salts thereof have a human renin inhibitory effect when administered orally and are useful for treatment of hypertension, especially renin-associated hypertension.
    揭示了作为治疗剂有用的新型氨基酸衍生物。这些氨基酸衍生物及其药用盐在口服时具有人类肾素抑制作用,并且对治疗高血压,特别是与肾素相关的高血压有用。
  • WO2008/97673
    申请人:——
    公开号:——
    公开(公告)日:——
  • COMPOUNDS AND COMPOSITIONS AS CHANNEL ACTIVATING PROTEASE INHIBITORS
    申请人:Tully David C.
    公开号:US20100239551A1
    公开(公告)日:2010-09-23
    The invention provides compounds and pharmaceutical compositions thereof, which are useful for modulating chan-nel activating proteases, and methods for using such compounds to treat, ameliorate or prevent a condition associated with a channel activating protease, including but not limited to prostasin, PRSS22, TMPRSS11 (e.g., TMPRSS11B, TMPRSSI1E), TMPRSS2, TMPRSS3, TMPRSS4 (MTSP-2), matriptase (MTSP-1), CAP2, CAP3, trypsin, cathepsin A, or neutrophil elastase.
  • New Synthetic Technology for Efficient Construction of α-Hydroxy-β-amino Amides via the Passerini Reaction<sup>1</sup>
    作者:J. Edward Semple、Timothy D. Owens、Khanh Nguyen、Odile E. Levy
    DOI:10.1021/ol0061485
    日期:2000.9.1
    [reaction: see text] The Passerini reaction of N-protected amino aldehydes, isonitriles, and TFA using pyridine-type bases proceeds under mild conditions and directly affords alpha-hydroxy-beta-amino amide derivatives in moderate to high yields. These adducts are readily hydrolyzed to alpha-hydroxy-beta-amino carboxylic acids. Application of these key intermediates to concise syntheses of P(1)-alpha-ketoamide
    [反应:见正文]使用吡啶型碱的N-保护的氨基醛,异腈和TFA的Passerini反应在温和的条件下进行,并以中等至高收率直接提供α-羟基-β-氨基酰胺衍生物。这些加合物容易水解成α-羟基-β-氨基羧酸。说明了这些关键中间体在简明P(1)-α-酮酰胺蛋白酶抑制剂合成中的应用。
查看更多